14
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Comparison Between Blood Fibrinolytic Activity in the Legs and Arms and its Possible Role in Phlebothrombosis

      research-article

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A significant increase of the fibrinolytic activity in the femoral vein blood after exercise of the legs has been observed. It is suggested that this increase is beneficial to the human organism from the point of view of practical therapeutics since fibrin clots oftener than platelet thrombi cause venous obstruction.The fibrinolytic activity was found to be lower in the blood obtained from the femoral vein in subjects confined to bed. It is tentatively suggested that this decrease may at least to some extent play a part in the increased incidence of phlebothrombosis in the lower limbs of patients who are bed-ridden.It is further suggested that the increase in the activator content in the blood after exercise of the leg is due to larger amounts of activator being contributed by the muscles during the accelerated bloodflow.

          Related collections

          Author and article information

          Journal
          JVR
          J Vasc Res
          10.1159/issn.1018-1172
          Journal of Vascular Research
          S. Karger AG
          1018-1172
          1423-0135
          1971
          1971
          18 September 2008
          : 8
          : 2
          : 83-88
          Affiliations
          Departments of Medicine and Medical Statistics, University of Newcastle and Royal Victoria Infirmary, Newcastle upon Tyne
          Article
          157863 Angiologica 1971;8:83–88
          10.1159/000157863
          54c0eaaf-e088-4954-bbb8-f72bf4178fca
          © 1971 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 6
          Categories
          Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Fibrinolysis,Fibrinolysis in phlebothrombosis,Phlebothrombosis,Fibrinolytic activity in legs,Fibrinolytic activity in arms

          Comments

          Comment on this article